Search Results

There are 44383 results for: content related to: Toward Greener Therapeutic Proteins

  1. Environmental Considerations in Biologics Manufacture

    Green Chemistry in the Pharmaceutical Industry

    Peter J. Dunn, Andrew S. Wells, Michael T. Williams, Pages: 311–331, 2010

    Published Online : 19 MAR 2010, DOI: 10.1002/9783527629688.ch15

  2. Design and Optimization of Manufacturing

    Process Scale Purification of Antibodies

    Uwe Gottschalk, Pages: 263–291, 2008

    Published Online : 15 AUG 2008, DOI: 10.1002/9780470444894.ch13

  3. Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation

    Biotechnology Journal

    Volume 9, Issue 6, June 2014, Pages: 766–775, Nikolaus Hammerschmidt, Anne Tscheliessnig, Ralf Sommer, Bernhard Helk and Alois Jungbauer

    Version of Record online : 4 APR 2014, DOI: 10.1002/biot.201300480

  4. Fed-batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty

    Biotechnology and Bioengineering

    Volume 110, Issue 1, January 2013, Pages: 206–219, James Pollock, Sa V. Ho and Suzanne S. Farid

    Version of Record online : 6 AUG 2012, DOI: 10.1002/bit.24608

  5. Technologies with Abstracts and Technology Costs

    Wiley's Remediation Technologies Handbook: Major Contaminant Chemicals and Chemical Groups

    Jay H. Lehr, Pages: 320–1147, 2005

    Published Online : 28 JAN 2005, DOI: 10.1002/0471655473.ch3

  6. You have free access to this content

    Biopharmaceutical Production Technology, Volume 1 & Volume 2

    Ganapathy Subramanian, Pages: 859–883, 2012

    Published Online : 15 OCT 2012, DOI: 10.1002/9783527653096.index

  7. Knowledge of ADME of Therapeutic Proteins in Adults Facilitates Pediatric Development

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Omoniyi J. Adedokun and Zhenhua Xu

    Published Online : 30 DEC 2015, DOI: 10.1002/9780470571224.pse555

  8. Process Economic Drivers in Industrial Monoclonal Antibody Manufacture

    Process Scale Purification of Antibodies

    Uwe Gottschalk, Pages: 239–261, 2008

    Published Online : 15 AUG 2008, DOI: 10.1002/9780470444894.ch12

  9. The Oxford Laser Prostate Trial: economic issues surrounding contact laser prostatectomy

    British Journal of Urology

    Volume 77, Issue 3, March 1996, Pages: 386–390, S.R. Keoghane, K.C. Lawrence, A.M. Gray, D. Chappel, A.M. Hancock and D.W. Cranston

    Version of Record online : 29 OCT 2003, DOI: 10.1046/j.1464-410X.1996.81811.x

  10. Analysis of hospital costs as a basis for pricing services in Mali

    The International Journal of Health Planning and Management

    Volume 22, Issue 3, July/September 2007, Pages: 205–224, Martine Audibert, Jacky Mathonnat, Delphine Pareil and Raymond Kabamba

    Version of Record online : 5 JUN 2007, DOI: 10.1002/hpm.880

  11. Geogenic versus Anthropogenic: Hydrocarbons in the Spoil from the Falkenstein and Spering Tunnels (A9 Pyhrn Autobahn, Austria)

    Geomechanics and Tunnelling

    Volume 8, Issue 4, August 2015, Pages: 356–363, Dr. Reinhard Gratzer, Priv.-Doz. Dr. Achim Bechtel, Univ.-Prof. Dr. Reinhard F. Sachsenhofer and Ao.-Prof. Dr. Hans-Jürgen Gawlick

    Version of Record online : 3 AUG 2015, DOI: 10.1002/geot.201500018

  12. Immunogenicity of Therapeutic Proteins

    Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals

    Feroz Jameel, Susan Hershenson, Pages: 105–117, 2010

    Published Online : 5 AUG 2010, DOI: 10.1002/9780470595886.ch4

  13. Aggregation and Immunogenicity of Therapeutic Proteins

    Aggregation of Therapeutic Proteins

    Vasco Filipe, Andrea Hawe, Huub Schellekens, Wim Jiskoot, Pages: 403–433, 2010

    Published Online : 5 AUG 2010, DOI: 10.1002/9780470769829.ch10

  14. Quality attributes of recombinant therapeutic proteins: An assessment of impact on safety and efficacy as part of a quality by design development approach

    Biotechnology Progress

    Volume 28, Issue 3, May/June 2012, Pages: 608–622, Alex Eon-Duval, Hervé Broly and Ralf Gleixner

    Version of Record online : 2 MAY 2012, DOI: 10.1002/btpr.1548

  15. Using Pharmacometrics in the Development of Therapeutic Biological Agents

    Pharmacometrics: The Science of Quantitative Pharmacology

    Ene I. Ette, Paul J. Williams, Pages: 993–1033, 2006

    Published Online : 18 MAY 2006, DOI: 10.1002/9780470087978.ch41

  16. Cost of screening for cancerous and precancerous lesions of the cervix

    Diagnostic Cytopathology

    Volume 27, Issue 4, October 2002, Pages: 251–257, Estelle Méréa, Catherine Le Galès, Beatrix Cochand-Priollet, Isabelle Cartier, Patricia de Crémoux, Marie Cécile Vacher-Lavenu, Philippe Vielh and Joël Coste

    Version of Record online : 30 SEP 2002, DOI: 10.1002/dc.10177

  17. Comparison of different options for harvest of a therapeutic protein product from high cell density yeast fermentation broth

    Biotechnology and Bioengineering

    Volume 94, Issue 1, 5 May 2006, Pages: 91–104, Alice Wang, Rachael Lewus and Anurag S. Rathore

    Version of Record online : 26 JAN 2006, DOI: 10.1002/bit.20816

  18. You have free access to this content
    Impact of product-related factors on immunogenicity of biotherapeutics

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 2, February 2011, Pages: 354–387, Satish Kumar Singh

    Version of Record online : 25 AUG 2010, DOI: 10.1002/jps.22276

  19. Solid-Solution Strengthened Ni-base Alloys

    Welding Metallurgy and Weldability of Nickel-Base Alloys

    John N. DuPont, John C. Lippold, Samuel D. Kiser, Pages: 47–156, 2009

    Published Online : 17 NOV 2009, DOI: 10.1002/9780470500262.ch3

  20. You have free access to this content
    Two Decades of Publishing Excellence in Pharmaceutical Biotechnology

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 2, February 2015, Pages: 290–300, David B. Volkin, Susan Hershenson, Rodney J. Y. Ho, Susumu Uchiyama, Gerhard Winter and John F. Carpenter

    Version of Record online : 1 DEC 2014, DOI: 10.1002/jps.24285